News
Novavax Soars
Digest more
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
Another Breakthrough Summit West in the books, and what an excellent event! We kicked off the day with former FDA head Robert ...
Novavax (NasdaqGS:NVAX) recently reported a significant financial turnaround for Q1 2025, demonstrating substantial revenue growth and net income improvements. The amending of its collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback